579 - Safety and Immunogenicity of Mpox Vaccination in Adolescents

Saturday, October 19, 2024

2:33 PM – 2:45 PM US PT

Location: 403 A

Presenting Author(s)

C. Mary Healy, MD, FIDSA (she/her/hers)

Associate Professor of Pediatrics, Infectious Diseases
Baylor College of Medicine
Houston, TX, United States

Slides

Co-Author(s)

C. Buddy Creech, MD, MPH

Director, Vanderbilt Vaccine Research Program
Vanderbilt University Medical Center
Nashville, TN, United States
SF

Sharon E. Frey, MD

Professor
Saint Louis University
St. Louis, Missouri, United States
AL

Andrea Lerner, MD

Medical Officer
DMID/NIAID/NIH
Rockville, Maryland, United States
KT

Kay Tomashek, M.D

Investigator
National Institutes of Health
Rockville, MD, United States
JB

John H. Beigel, MD

The National Institute of Allergy and Infectious Diseases, National Institutes of Health
Rockville, Maryland, United States

Disclosure(s):

C. Mary Healy, MD, FIDSA: Dexcom Inc: Stocks/Bonds (Public Company); Hillevax, Inc: Member of Advisory board; Intuitive Surgical Inc: Stocks/Bonds (Public Company); Quidel Corporation: Stocks/Bonds (Public Company); Vapotherm: Stocks/Bonds (Public Company)

C. Buddy Creech, MD, MPH: CommenseBio: Advisor/Consultant; GSK: Advisor/Consultant; Moderna: Advisor/Consultant, Grant/Research Support; TDCowen: Advisor/Consultant; UpToDate: Honoraria; Vedanta: Grant/Research Support

Sharon E. Frey, MD: Bavarian Nordic: Grant/Research Support; Saint Louis University (SLU): Grant/Research Support

Andrea Lerner, MD: No financial relationships to disclose

Kay Tomashek, M.D: No financial relationships to disclose

John H. Beigel, MD: No financial relationships to disclose